K Pharma (TSE:4896) Total Inventories : 円9 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is K Pharma Total Inventories?

K Pharma's total inventories for the quarter that ended in Mar. 2024 was 円9 Mil. K Pharma's average total inventories from the quarter that ended in Dec. 2023 to the quarter that ended in Mar. 2024 was 円10 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. K Pharma's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was 円244.57.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. K Pharma's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

K Pharma Total Inventories Historical Data

The historical data trend for K Pharma's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Total Inventories Chart

K Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Total Inventories

9.88

10.20

10.79

K Pharma Quarterly Data
	Dec21	Dec22	Jun23	Sep23	Dec23	Mar24
Total Inventories	Get a 7-Day Free Trial			10.20	8.95	9.38	10.79	9.36

K Pharma Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

K Pharma (TSE:4896) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

K Pharma's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is

	Net-Net Working Capital Per Share (Q: Mar. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(2934.171	+	0.75 * 0	+	0.5 * 9.364	-	100.737
-	0	-	0)	/	11.6046
=	244.57

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

K Pharma's Days Inventory for the three months ended in Mar. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2024 )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
	=	10.079	/	0	*	365 / 4
	=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

K Pharma's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Mar. 2024 )	/	Average Total Inventories (Q: Mar. 2024 )
	=	0	/	10.079
	=	0.00

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

K Pharma's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	10.079	/	0
	=

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

K Pharma Total Inventories Related Terms

Thank you for viewing the detailed overview of K Pharma's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

K Pharma (TSE:4896) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032

Website

https://en.kpharma.co.jp

K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines